BCM
ADNT icon

Bayesian Capital Management’s Adient ADNT Stock Holding History

Bayesian Capital Management’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,845
Closed -$531K – 576
2024
Q4 		$531K Buy
30,845
+11,600
+60% +$232K 0.07% 354
2024
Q3 		$434K Buy
+19,245
New +$440K 0.05% 405
2024
Q2 		– Sell
-9,600
Closed -$316K – 690
2024
Q1 		$316K Buy
+9,600
New +$327K 0.03% 542
2020
Q4 		– Sell
-11,200
Closed -$194K – 439
2020
Q3 		$194K Sell
11,200
-15,700
-58% -$274K 0.05% 443
2020
Q2 		$442K Sell
26,900
-8,200
-23% -$125K 0.1% 263
2020
Q1 		$318K Buy
+35,100
New +$707K 0.07% 432

Other funds holding ADNT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.83B AUM 34.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bayesian Capital Management's ADNT Position: Q1 2025 in Review

Bayesian Capital Management sold out of Adient (ADNT) in Q1 2025, closing a stake of 30,845 shares — an estimated $531K sold.

Bayesian Capital Management first reported a position in ADNT in Q1 2020 and held it in 6 quarters. The position peaked at $531K in Q4 2024. 270 funds tracked by Wall St. Rank hold ADNT as of Q1 2025.

  • Bayesian Capital Management reported no remaining Adient position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 30,845 Adient shares in Q1 2025, an estimated $531K.
  • Bayesian Capital Management first reported a position in Adient in Q1 2020 and held it in 6 quarters.
  • Bayesian Capital Management's Adient position peaked at $531K in Q4 2024.
  • 270 funds tracked by Wall St. Rank held Adient as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.